Avoro Capital Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366M | Sell |
|
|||||
|
2025
Q1 | $492M | Buy |
|
|||||
|
2024
Q4 | $412M | Buy |
|
|||||
|
2024
Q3 | $477M | Buy |
|
|||||
|
2024
Q2 | $447M | Sell |
|
|||||
|
2024
Q1 | $455M | Sell |
|
|||||
|
2023
Q4 | $318M | Hold |
|
|||||
|
2023
Q3 | $298M | Buy |
|
|||||
|
2023
Q2 | $301M | Buy |
|
|||||
|
2023
Q1 | $140M | Buy |
|
|||||
|
2022
Q4 | $112M | Buy |
|
|||||
|
2022
Q3 | $88.9M | Buy |
|
|||||
|
2022
Q2 | $70.6M | Buy |
|
|||||
|
2022
Q1 | $66.9M | Buy |
|
|||||
|
2021
Q4 | $33.2M | Buy |
|